|
|
|
|
| LEADER |
00000cam a2200000Ia 4500 |
| 001 |
ocn893456372 |
| 003 |
OCoLC |
| 005 |
20221028140140.0 |
| 008 |
141126t20142004xxuad b 001 0 eng d |
| 035 |
|
|
|a (Sirsi) i9780123820303
|
| 040 |
|
|
|a ESALI
|b spa
|d UV#
|
| 020 |
|
|
|a 9780123820303 (pasta dura)
|
| 035 |
|
|
|a (OCoLC)893456372
|
| 050 |
|
4 |
|a RS403
|b S54 2014
|
| 100 |
1 |
|
|a Silverman, Richard B.
|9 379881
|
| 245 |
1 |
4 |
|a The organic chemistry of drug design and drug action
|c Richard B. Silverman, Mark W. Holladay
|
| 250 |
|
|
|a Third edition.
|
| 260 |
|
|
|a San Diego, United States :
|b Academic Press-Elsevier,
|c 2004, 2014.
|
| 300 |
|
|
|a xviii, 517 páginas :
|b ilustraciones (algunas a color), gráficos ;
|c 28 cm.
|
| 504 |
|
|
|a Incluye bibliografías e índice.
|
| 650 |
|
4 |
|9 3738
|a Química farmacéutica
|
| 650 |
|
4 |
|9 360040
|a Química bioorgánica
|
| 650 |
|
4 |
|a Medicamentos
|x Investigación.
|
| 650 |
|
7 |
|a Farmacocinética
|9 355350
|
| 700 |
1 |
|
|a Holladay, Mark W.
|
| 901 |
|
|
|a Z0
|b UV#
|
| 902 |
|
|
|a DGBUV
|
| 596 |
|
|
|a 15
|
| 942 |
|
|
|c LIBRO
|
| 999 |
|
|
|c 287308
|d 287308
|
